ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

RAPT RAPT Therapeutics Inc

8.10
-0.08 (-0.98%)
Última actualización: 11:02:55
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
RAPT Therapeutics Inc RAPT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.08 -0.98% 8.10 11:02:55
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.31 8.06 8.4278 8.18
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
09/4/202411:00GLOBERAPT Therapeutics Announces Promising Results from Phase 2..
07/3/202415:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202407:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202407:03EDGAR2Form 8-K - Current report
07/3/202407:00GLOBERAPT Therapeutics Reports Fourth Quarter and Full Year 2023..
05/3/202415:30GLOBERAPT Therapeutics Announces Multiple Late-Breaking..
22/2/202416:13EDGAR2Form 8-K - Current report
20/2/202415:29EDGAR2Form 8-K - Current report
20/2/202406:30GLOBERAPT Therapeutics Announces Clinical Hold on Studies..
14/2/202407:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202407:00GLOBERAPT Therapeutics Bolsters Leadership Team with the..
31/1/202407:00GLOBERAPT Therapeutics to Participate in the Guggenheim..
02/1/202407:00GLOBERAPT Therapeutics to Present at the 42nd Annual J.P. Morgan..
27/11/202307:00GLOBERAPT Therapeutics Announces Publication of Phase 1a/1b..
13/11/202307:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202307:03EDGAR2Form 8-K - Current report
13/11/202307:00GLOBERAPT Therapeutics Reports Third Quarter 2023 Financial..
03/11/202311:03EDGAR2Form 8-K - Current report
03/11/202311:00GLOBERAPT Therapeutics Announces Positive Data, Including..
01/11/202315:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
18/10/202308:00GLOBERAPT Therapeutics Announces Two FLX475 Presentations at the..
30/8/202315:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
17/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/8/202315:02EDGAR2Form 8-K - Current report
11/8/202307:57EDGAR2Form S-3 - Registration statement under Securities Act of..
11/8/202307:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202307:05EDGAR2Form 8-K - Current report
11/8/202307:00GLOBERAPT Therapeutics Reports Second Quarter 2023 Financial..
07/6/202307:00GLOBERAPT Therapeutics to Participate in the Goldman Sachs Global..
25/5/202316:00GLOBERAPT Therapeutics to Present Biomarker Data Corroborating..
11/5/202307:00GLOBERAPT Therapeutics Reports First Quarter 2023 Financial..
03/5/202307:00GLOBERAPT Therapeutics Announces the Appointment of Michael..

Su Consulta Reciente

Delayed Upgrade Clock